Abstract
A biopsy should be performed with relative promptness on any lesion that is clinically suspicious for melanoma, as early diagnosis is the key to a favorable prognosis. The gold standard for melanoma diagnosis is histologic assessment of a tissue biopsy specimen by a dermatopathologist or pathologist with experience in interpreting melanocytic lesions. The primary goal of a biopsy is to obtain a tissue sample that is sufficient to allow the pathologist to render an accurate histologic diagnosis and assess key prognostic features for microstaging, particularly tumor thickness, if the lesion is indeed melanoma. An accurate diagnosis and tumor microstaging in turn facilitates therapeutic planning with appropriate and expeditious treatment. In this chapter, we will describe important considerations when performing a biopsy of a lesion suspicious for melanoma, commonly used biopsy techniques, and their applications to maximize biopsy accuracy in the initial diagnosis of melanoma.
References
Balch CM et al (2001a) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648. https://doi.org/10.1200/JCO.2001.19.16.3635
Balch CM et al (2001b) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622–3634. https://doi.org/10.1200/JCO.2001.19.16.3622
Basler GC, Fader DJ, Yahanda A, Sondak VK, Johnson TM (1997) The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol 36:403–408
Bichakjian CK et al (2011) Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 65:1032–1047. https://doi.org/10.1016/j.jaad.2011.04.031
Bolognia JL (2000) I. Biopsy techniques for pigmented lesions. Dermatol Surg 26:89–90
Bong JL, Herd RM, Hunter JA (2002) Incisional biopsy and melanoma prognosis. J Am Acad Dermatol 46:690–694
Christenson LJ, Phillips PK, Weaver AL, Otley CC (2005) Primary closure vs second-intention treatment of skin punch biopsy sites: a randomized trial. Arch Dermatol 141:1093–1099. https://doi.org/10.1001/archderm.141.9.1093
Egnatios GL et al (2011) The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma. Am J Surg 202:771–777; discussion 777–778. https://doi.org/10.1016/j.amjsurg.2011.06.037
Houghton AN et al (2006) Melanoma. J Natl Compr Cancer Netw 4:666–684
Jellinek N (2007) Nail matrix biopsy of longitudinal melanonychia: diagnostic algorithm including the matrix shave biopsy. J Am Acad Dermatol 56:803–810. https://doi.org/10.1016/j.jaad.2006.12.001
Karimipour DJ et al (2005) Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J Am Acad Dermatol 52:798–802. https://doi.org/10.1016/j.jaad.2004.09.031
Lederman JS, Sober AJ (1985) Does biopsy type influence survival in clinical stage I cutaneous melanoma? J Am Acad Dermatol 13:983–987
Macy-Roberts E, Ackerman AB (1982) A critique of techniques for biopsy of clinically suspected malignant melanomas. Am J Dermatopathol 4:391–398
Martin RC 2nd, Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Edwards MJ, McMasters KM (2005) Is incisional biopsy of melanoma harmful? Am J Surg 190:913–917. https://doi.org/10.1016/j.amjsurg.2005.08.020
Mills JK, White I, Diggs B, Fortino J, Vetto JT (2013) Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma. Am J Surg 205: 585–590; discussion 590. https://doi.org/10.1016/j.amjsurg.2013.01.023
Mir M, Chan CS, Khan F, Krishnan B, Orengo I, Rosen T (2013) The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival. J Am Acad Dermatol 68:452–458. https://doi.org/10.1016/j.jaad.2012.08.005
Molenkamp BG, Sluijter BJ, Oosterhof B, Meijer S, van Leeuwen PA (2007) Non-radical diagnostic biopsies do not negatively influence melanoma patient survival. Ann Surg Oncol 14:1424–1430. https://doi.org/10.1245/s10434-006-9302-7
Negin BP, Riedel E, Oliveria SA, Berwick M, Coit DG, Brady MS (2003) Symptoms and signs of primary melanoma: important indicators of Breslow depth. Cancer 98:344–348. https://doi.org/10.1002/cncr.11513
Ng PC, Barzilai DA, Ismail SA, Averitte RL Jr, Gilliam AC (2003) Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth? J Am Acad Dermatol 48:420–424. https://doi.org/10.1067/mjd.2003.106
Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW (2010) The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch Dermatol 146:234–239. https://doi.org/10.1001/archdermatol.2010.14
Pardasani AG, Leshin B, Hallman JR, White WL (2000) Fusiform incisional biopsy for pigmented skin lesions. Dermatol Surg 26:622–624
Prieto VG et al (2003) Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol 120:203–208. https://doi.org/10.1309/J1Q0-V35E-UTMV-R193
Rich P (2001) Nail biopsy: indications and methods. Dermatol Surg 27:229–234
Rodrigues LK et al (2000) Fine needle aspiration in the diagnosis of metastatic melanoma. J Am Acad Dermatol 42:735–740
Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM (2002) Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 95:1562–1568. https://doi.org/10.1002/cncr.10880
Scolyer RA, Thompson JF, McCarthy SW, Gershenwald JE, Ross MI, Cochran AJ (2005) Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg 201:821–823; author reply 823–824. https://doi.org/10.1016/j.jamcollsurg.2005.07.017
Scope A et al (2008) The “ugly duckling” sign: agreement between observers. Arch Dermatol 144:58–64. https://doi.org/10.1001/archdermatol.2007.15
Smith-Zagone MJ, Schwartz MR (2005) Frozen section of skin specimens. Arch Pathol Lab Med 129:1536–1543. https://doi.org/10.1043/1543-2165(2005)129[1536:FSOSS]2.0.CO;2
Sober AJ, Balch CM (2007) Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol 14:274–275. https://doi.org/10.1245/s10434-006-9301-8
Somach SC, Taira JW, Pitha JV, Everett MA (1996) Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch Dermatol 132:1297–1302
Stell VH, Norton HJ, Smith KS, Salo JC, White RL Jr (2007) Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol 14:893–898. https://doi.org/10.1245/s10434-006-9240-4
Stojadinovic A, Allen PJ, Clary BM, Busam KJ, Coit DG (2002) Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 235:92–98
Swanson NA, Lee KK, Gorman A, Lee HN (2002) Biopsy techniques. Diagnosis of melanoma. Dermatol Clin 20:677–680
Wazaefi Y et al (2013) Evidence of a limited intra-individual diversity of nevi: intuitive perception of dominant clusters is a crucial step in the analysis of nevi by dermatologists. J Invest Dermatol 133:2355–2361. https://doi.org/10.1038/jid.2013.183
Zager JS et al (2011) Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. J Am Coll Surg 212:454–460; discussion 460–452. https://doi.org/10.1016/j.jamcollsurg.2010.12.021
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Smith, N., Johnson, T.M., Kelly, J.W., Sober, A., Bichakjian, C. (2019). Biopsy of Suspected Melanoma. In: Balch, C., et al. Cutaneous Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-46029-1_10-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-46029-1_10-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-46029-1
Online ISBN: 978-3-319-46029-1
eBook Packages: Springer Reference MedicineReference Module Medicine